Metformin can effectively inhibit HCC growth by inhibiting mTOR through the phosphatidylinositol-3-kinase (PI3K)/protein kinase B(AKT)/mTOR signal pathway (14). Here, AKT1 is linked to hepatocellular carcinoma.